Arteriovenous Malformation Press ReleasesA Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)
Thursday, May 9, 2013
Upon the recommendation of the ARUBA Data and Safety Monitoring Board, the NINDS has stopped enrollment of patient volunteers
into the trial. Under the experimental conditions in this trial, the interim analysis of data collected to date shows that
medical management is superior to intervention in patients with unruptured brain arteriovenous malformations (AVMs). The DSMB
further recommended extended follow-up to determine whether the disparity in event rates will persist over time.